Status:
COMPLETED
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
Lead Sponsor:
University of Rochester
Conditions:
Hematologic Malignancies
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies
Detailed Description
Older adults with hematologic malignancies receive more aggressive inpatient care at the end of life compared to patients with solid tumors. Advance care planning may promote early serious illness con...
Eligibility Criteria
Inclusion
- Age ≥60 years
- A diagnosis of hematologic malignancy \[including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment\]
- Able to provide informed consent
- Being managed in the inpatient setting
- English-speaking
Exclusion
- • None
Key Trial Info
Start Date :
September 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2024
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT05433090
Start Date
September 6 2022
End Date
November 14 2024
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14642